First US leukemia patient dosed with Smart Immune's investigational SMART101 cell therapy
First US leukemia patient dosed with Smart Immune’s investigational SMART101 cell therapy - read this article along with other careers information, tips and advice on BioSpace
New York United States Memorial Sloan Kettering Cancer Center France General Karine Rossignol Protcell At Memorial Sloan Kettering Cancer Center
Source: biospace.com